One heartbeat ahead™

The Pioneers of Vascular Treatment Devices

Eurocor Tech is a rapidly growing European Life Sciences Technology corporation specializing in the research, development and manufacture of interventional cardiovascular and endovascular treatment devices made in Europe for the world.

Eurocor Tech FREEWAY™ 035 Paclitaxel-eluting PTA balloon dilatation catheter shape 1 shape 2

treated patients






clinical studies

One heartbeat ahead™

Discover Eurocor


Our mission is to enable healthcare providers and physicians to improve and extend life through minimally invasive device innovations of outstanding quality. Eurocor Tech has successfully provided healthcare solutions for more than 20 years  and is currently present in more than 60 countries worldwide.


Clinical research

Eurocor Tech puts safety for patients and users first. We have conducted randomized-clinical trials and collected registries of >1600 Patients worldwide. The results clearly underlined safety and efficacy of our products and have been presented at international congresses as well as published in peer-reviewed journals.

Clinical research


We provide physicians with innovative drug-coated balloon and stent devices as well as uncoated pre-dilatation balloons. Eurocor Tech products are indicated for minimally invasive cardiovascular and peripheral surgery and comply with biological and biomechanical principles to offer highly flexible, adaptable solutions.


News from Eurocor

What’s new from
the company

Eurolimus™: award of CE mark and start of commercial sale

Eurocor is proud to announce the CE-marking and commercial launch of Eurolimus™. Eurolimus™ Sirolimus eluting coronary stent system offers great product features to further improve the quality and efficacy stenting procedures. The product features and open-cell desgin with interlinks allowing for high flexibility and overexpansion capabilities while offering one of the lowest strut thicknesses in […]

read more

Eurocor at LINC 2021

We are proud to announce that Eurocor’s FREEWAY Stent study (used stent type subgroup analysis) will be part of the selected abstracts during LINC 2021 (January 25th – 29th, 2021).

read more

New Training Module: Cost Effectiveness of DCBs

Discover our new training module on the cost-efficiency of DCB treatment compared to alternative intervention options. You can sign up for a training through your sales representative directly or by reaching out to

read more